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Summary 
Several studies have shown that CC chemokines attract T  lymphocytes, and that CD45RO +, 
memory phenotype cells are considered to be the main responders. The results,  however, have 
often been contradictory and the role of lymphocyte activation and proliferation has remained 
unclear. Using CD45RO + blood lymphocytes cultured under different stimulatory conditions, 
we have now studied chemotaxis as well as chemokine receptor expression. Expression of the 
RANTES/MIP-lc~ receptor (CC-CK1K1) and the MCP-1  receptor (CC-CKR2)  was highly 
correlated with migration toward RANTES,  MCP-1,  and  other CC  chemokines,  and was 
strictly dependent on the presence of IL-2 in the culture medium. Migration and receptor ex- 
pression were rapidly downregulated when IL-2 was withdrawn, but were fully restored when 
IL-2 was added again.  The effect oflL-2 could be partially mimicked by IL-4, IL-10, or IL-12, 
but not by IL-13, IFN',/, IL-1[3, TNF-el, or by exposure to anti-CD3, anti-CD28 or phytohe- 
magglutinin. Activation of fully responsive lymphocytes through the TCP,./CD3 complex and 
CD28  antigen actually had the opposite effect. It rapidly downregulated receptor expression 
and  consequent migration  even in  the  presence  of IL-2.  In  contrast  to  the  effects on  CC 
chemokine receptors, stimulation ofCD45ILO + T lymphocytes with IL-2 neither induced the 
expression of the CXC  chemokine receptors, IL8-R1  and IL8-P-.2,  nor chemotaxis to IL-8. 
The prominent role of IL-2 in CC chemokine responsiveness of lymphocytes suggests that IL- 
2-mediated expansion is a prerequisite for the recruitment of antigen-activated T  cells into sites 
of  immune and inflammatory reactions. 
S 
everal chemokines of the CC subfamily are critically in- 
volved in the regulation of phagocyte and lymphocyte 
recruitment in many pathological situations (1, 2). The ef- 
fects of CC chemokines on monocytes (3-5), basophil, and 
eosinophil leukocytes (6, 7) are well defined and generally 
accepted. The situation is more complex for lymphocytes. 
T lymphocytes were shown to migrate toward RANTES, the 
macrophage inflammatory proteins MIP-1 ot and MIP-lJ3 (8- 
10)  and,  more  recently,  to  respond  to  the  monocyte 
chemotactic proteins MCP-1, MCP-2, and MCP-3, which 
are highly effective on CD4 + and CD8 + T  cells  (11-13). 
All these CC chemokines induced a transient cytosolic free 
Ca  2+ rise in T cell clones, which was prevented by B. pertus- 
sis toxin (11) suggesting the involvement of G protein-cou- 
pled receptors (14).  Neither Ca  2+ changes nor chemotaxis, 
however, were observed in freshly isolated blood lympho- 
cytes, suggesting that activation is necessary. 
Several chemokine receptors were identified by cloning 
of their corresponding cDNAs from phagocyte-derived li- 
braries  (15-22).  CXC  chemokine receptors are expressed 
primarily in neutrophils (15,  16, 23), whereas CC chemo- 
kine  receptors (CC-CKR) 1 are  generally found on other 
leukocytes (17-22). No corresponding cDNA has been ob- 
tained  from  lymphocytes,  however,  and  little  is  known 
about the expression of chemokine receptors in these cells. 
We have now studied the migration responses to RANTES, 
MCP-1, and other chemokines, and the expression of the 
relevant receptors, CC-CKR1  (RANTES/MIP-Ici recep- 
tor)  and  CC-CKR2  (MCP-t  receptor),  in  CD45KO + 
blood lymphocytes exposed to different stimulatory condi- 
tions. The data presented in this paper show that lympho- 
cyte responses to chemokines closely correlate with the ex- 
pression  of transcripts  for chemokine  receptors,  and  that 
receptor expression  and  consequent  ability  to  migrate  is 
strictly dependent on IL-2. Our results suggest that stimula- 
tion by IL-2 make T  lymphocytes competent for recruit- 
IAbbreviations used in  this paper: CC-CKR., CC  chemokine receptor; 
MCP, monocyte chemotactic  protein; MtP, macrophage inflammatory 
protein. 
569  j. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/96/08/569/09 $2.00 
Volume 184 August 1996 569-577 ment by chemokines into sites of immune and inflamma- 
tory reactions. 
Table  1.  Phenotypic Analysis  of"Cultured CD45RO + 
Lymphocytes 
Materials and Methods 
Cytokines.  All chemokines used,  MCP-I, MCP-2, MCP-3, 
MIP-lcx,  MIP-I[3,  RANTES,  and  IL-8,  were  synthesized  by 
solid-phase methods using the tertiary butyloxycarbonyl  and ben- 
zyl protection methods (24). Human recombinant IL-10,  IL-12, 
and IL-13 were obtained from R&D Systems Ltd., Minneapolis, 
MN. Other human recombinant cytokines were kindly provided 
by Dr.  A. Lanzavecchia  (Basel Institute for  Immunology, Basel, 
Switzerland;  IL-2),  Chiron Corp.  (Emeryville,  CA; IL-4,  Hoff- 
mann-La Roche  Ltd.  (Basel, Switzerland;  TNF0t),  Ciba-Geigy 
Ltd.  (Basel, Switzerland;  IL-1[3), and Bioferon (Laupheim,  Ger- 
many; INFy). 
Antibodies.  A monoclonal antibody (mAb) to CD28 (9.3) was 
provided as ascites by Dr. J. Ledbetter (Bristol-Myers Squibb, Se- 
attle,  WA)  and  mAbs  to  CD3  (TR66,  IgG1),  CD8  (OKT8, 
IgG2a),  CD16  (B-73,  IgGl), and CD45RO  (UCHL-1, IgG2a) 
by Dr.  A.  Lanzavecchia.  mAbs to  CD4  (13B8.2,  IgG1),  CD14 
(RM052,  IgG2a),  and  CD20  (B9E9,  lgG2a)  were  purchased 
from  Immunotech (Marseille,  France);  mouse  isotype  controls 
(IgG1,  IgG2a)  from  Sigma  Chemical  Co.  (St. Louis,  MO); 
FITC-conjugated  goat  anti-mouse  IgG  from  Dako  Corp. 
(Carpinteria,  CA);  and  goat  anti-mouse lgG  microbeads  from 
Miltenyi Biotec (Bergisch-Gladbach,  Germany). 
Cell Preparation and Culture.  Human  peripheral  blood  lym- 
phocytes  (PBL) were isolated  from donor blood huffy coats by 
centrifugation on Ficoll-Paque followed by Percoll  (25). For the 
isolation of CD45RO + lymphocytes,  the PBL were incubated for 
25 nfin at 6-10~  with anti-CD45RO, washed  twice and incu- 
bated for  15  min at 6-10~  with MACS goat  anti-mouse IgG 
microbeads  (26). After  washing twice,  the  microbead-coupled 
lymphocytes  were  magnetically separated.  The  cells obtained 
were cultured in RPM1  1640 supplemented with 1% glutamine, 
non-essential amino acids, sodium pyruvate and kanamycin, 5 X 
10  s  M  2-mercaptoethanol (all from  Gibco,  Paisley,  Scotland) 
and 5% human serum (Swiss Red Cross Laboratory,  Bern, Swit- 
zerland). When indicated, human recombinant IL-2 (400 U/ml) 
was added to this medium. Throughout the whole culture period 
the cell density was kept between 1 and 2.5 X 106 cells/ml by di- 
luting the  proliferating cells with  medium.  The  phenotype of 
CD45RO + lymphocytes conditioned with  IL-2  (Table  1)  was 
determined by flow  cytometry (FACScan|  Becton Dickinson, 
Mountain View, CA) after staining with mouse mAbs and FITC- 
conjugated goat anti-mouse lgG. 
Treatment with Anti-CD3 and Anti-CD28.  Plates  precoated with 
10  txg/ml of TR66 were  used  for stimulation with anti-CD3, 
whereas anti-CD28 (9.3) was added  in soluble form (1:250 dilu- 
tion). In these experiments,  CD45RO + lymphocytes were always 
used at the density of 2 X 106 cells per ml. 
Lymphocyte Chemotaxis.  Cell migration was measured  in 48- 
well chemotaxis  chambers (Neuro Probe Inc., Cabin John, MD) 
(11). Chemokines in Hepes-buffered RPMI  1640 supplemented 
with 1% pasteurized plasma protein (Swiss Red Cross Laboratory) 
were added  to the lower and 100,000 cells in the same medium 
to  the  upper  wells.  Polyvinylpyrrolidone-free polycarbouate 
membranes with 3-1xm pores coated with type IV collagen were 
used.  After  incubation for  l  h  at  37~  the membrane was re- 
moved, washed  on the upper side with PBS,  fixed and stained. 
Migrated  cells were counted microscopically  at  X 1000 magnifi- 
Surface marker  Percent staining  Range 
CD3  95.8  +  4.9  86.2-98.9 
CD4  30.3  --_ 5.8  24.6-38.4 
CD8  43.3  --_ 13.0  23.4-58.4 
CD14  1.0 _+ 0.4  0.6-1.5 
CD16  3.5  +  4.0  0.6-9.6 
CD20  0.6 +  0.2  0.0-2.8 
CD45RO  98.6  --_ 8.9  94.4-99.8 
CD45RO + lymphocytes cultured for 10 to  16 d in the presence of 
400 U/ml IL-2 were stained with the appropriate mouse monoclonal 
antibodies followed by FITC-conjugated goat anti-mouse lgG. The 
percent of cells expressing the indicated antigen was determined by a 
FACScan  |  flow cytometer. Mean values +  SD obtained with cells 
from seven different donors. 
cation in five randomly selected  fields per well.  All assays were 
performed in triplicate. 
Northern Blot Analysis.  Total lymphocyte RNA was extracted 
by the acid guanidinium  thiocyanate phenol-chloroform method 
(27) or the RNAzol B method as recommended by the supplier 
(Tel-Test Inc., Friendswood, TX). Samples of 10 p~g RNA were 
fractionated  on 0.8% denaturing agarose-formaldehyde  gels (28), 
vacuum-transferred onto  Nytran membranes and immobilized. 
The following hybridization probes  were used: A  478-bp Bstl- 
Clat fragment for CC-CKR2 (t9), a 360-bp PCR fragment cor- 
responding to an internal region in CC-CKR1 (17, 18), a 562-bp 
BstI-Bglll fragment for IL-8R1/2 (23), and a 308-bp Sacl-PstI 
fragment for the IL-2 receptor alpha chain (29). The probes were 
labeled  with  [cx-32pldATP using a  random primer labeling kit 
(Boehringer Ltd., Mannheim, Germany) and used for hybridiza- 
tion at >2  ￿  106 cpm/ml in the presence  of 50% formanaide at 
42~  for 24 h (28). The membranes were washed to a stringency 
of 0.25  ￿  SSC, 0.1% SDS at 65~  and exposed to screens which 
were subsequently analyzed  using a phosphorimager (Molecular 
Dynamics Inc., Sunnyvale, CA)  and the  ImageQuant software. 
Integrated counts of the 32p-labeled chemokine receptor RNA 
were expressed relative to the corresponding ethidium bromide- 
stained  28S  RNA.  After  each  hybridization the  probe was  re- 
moved by washing in 50% formamide,  0.1  ￿  SSC, 0.1% SDS at 
65~  for 30 min. 
Results 
Induction of Chemotactic Responsiveness by IL-2.  Freshly 
isolated CD45RO +  lymphocytes did  not migrate  toward 
MCP-1, RANTES or IL-8, and did not acquire migratory 
properties after culturing for up to  t0 d  in medium alone 
(Fig.  1 A).  When the  culture medium was  supplemented 
with IL-2, however, the cells became responsive to MCP-I 
and RANTES, as shown by the progressive increase in mi- 
gration from day 4  through day t5, but not to IL-8. Since 
lymphocyte activity may vary with the immune state of the 
donor, the  effect of conditioning with IL-2 was tested on 
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Figure  1.  Induction  of lymphocyte responsive- 
ness to chemokines by IL-2. (A) Time course. 1.5 X 
106 CD45RO + lymphocytes/ml were cultured in 
the  medium  described in  Materials and Methods 
without  additions (-IL-2) or with 400 U/ml IL-2 
(+IL-2).  1  p~g/ml PHA was  added at  day  zero 
(+IL-2/PHA). Shown is the number of migrating 
cells (mean -+ SD per five high-power fields in trip- 
licate wells) in the presence of 1 nM MCP-1,  10 
nM  RANTES  (maximum effective concentra- 
tions), and 10 nM IL-8. The data are representative 
for four independent experiments. (B) Concentra- 
tion-dependent  migration of CD45RO + lympho- 
cytes cultured  for  12  d  in the  presence of IL-2. 
Mean  numbers  of migrating  cells are  shown  as 
above. The data are representative of three inde- 
pendent experiments. 
CD45RO + cells from 15 different individuals. While fresh 
cells  consistently  failed  to  respond,  treatment  with  IL-2 
elicited  migration  toward  MCP-1  and  R.ANTES  in  all 
cases. Addition of the mitogenic lectin phytohemagglutinin 
delayed the  effect of IL-2,  and  migration toward MCP-1 
and R_ANTES was  observed only after 9  instead of 4  d  of 
culture  (Fig.  1 A).  These  results indicate that  chemotactic 
responsiveness was induced by IL-2 but was not necessarily 
related to blast formation and proliferation of the T  cells. 
As shown in Fig. 1B, IL-2 conditioned CD45RO + lym- 
phocytes responded not only to MCP-1  and RANTES  but 
also to MCP-2, MCP-3, MIP-loL, and MIP-I[~, while IL-8 
was inactive. Except for RANTES, for which a plateau was 
obtained above  10  nM,  a  typically bimodal concentration 
dependence  between  0.001  nM  and  1  btM  was  observed 
for all CC  chemokines. In three independent experiments, 
the highest numbers of migrated cells counted in five high- 
power fields (mean  +-  SEM),  were 209  +  34 for MCP-1, 
161  +_ 32 for MCP-2,  181  +  41 for MCP-3, 204  +  23 for 
RANTES,  140  ---  10 for MIP-lcx and  126  +-  7  for MIP- 
113,  whereas  random  migration  (no  chemokine  added) 
amounted to 36  +  1. Based on the concentration at which 
maximum  migration was  reached,  MCP-1  was  more  po- 
tent  than  MCP-2,  RANTES,  MIP-lcx,  and  MIP-I[3 
which were  superior to MCP-3.  Overall, the responses of 
CD45RO + lymphocytes conditioned with IL-2 were simi- 
lar  to  those  described  previously  for  cloned  CD4 +  and 
CD8 + T  cells (11). 
Functional Response Correlates with Chemokine Receptor Ex- 
pression.  The  effect of conditioning with  IL-2 on migra- 
tion toward MCP-1, RANTES and IL-8 was compared with 
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the  expression  of the  mRNA  for  the  relevant  receptors, 
CC-CKR1  (RANTES/MIP-10~-R),  CC-CKR2  (MCP-1- 
RA/B),  and  IL-8R1/2.  As shown  in  Fig.  2,  chemotactic 
responses  to  MCP-1  and  RANTES  increased  with  the 
level of expression of the respective receptors.  Transcripts 
for  CC-CKR1  and  CC-CKR2  were  undetectable  by 
Northern  analysis in  freshly isolated CD45RO +  lympho- 
cytes, which did not migrate, but became readily measur- 
able after about 4  d  when the cells began to show chemo- 
taxis, and increased markedly with time as did the numbers 
of migrating cells. A  similar IL-2-dependent increase in re- 
ceptor message  and  function  was  observed in  unfraction- 
ated blood lymphocytes (data not shown). The time course 
of receptor expression showed some  differences: the mes- 
sage of ~3.5  kb for CC-CKR2,  which was barely detect- 
able after 4  d, increased continuously in intensity until day 
12,  while  the  3  kb  message  for  CC  CKR1  was  already 
marked at day 4,  reached a maximum at day 6  to  10,  and 
decreased to an intermediate intensity at day 12.  No tran- 
scripts for the IL-8 receptors were detected in CD45RO + 
lymphocytes at  any time during the  treatment  with  IL-2, 
which fully agrees with the lack of IL-8-mediated chemo- 
taxis. IL-8 receptor message, however, was readily found in 
neutrophils which are the main target cells for IL-8. Neu- 
trophils  and  monocytes,  which  were  routinely  examined 
for  chemokine  receptor  expression  as  controls,  were  also 
positive for  CC-CKR1  transcripts,  whereas  expression of 
CC-CKR2  was only found in monocytes. 
As a possible correlate of the IL-2-dependent induction 
of lymphocyte responsiveness to  chemokines,  we  assessed 
the expression of the alpha subunit (Tac antigen) that is re- quired  for  formation  of  the  heterotrimeric,  high-affinity 
IL-2 receptor complex (30,  31).  As shown in Fig.  2, stimu- 
lation  of CD45RO  +  lymphocytes  with  IL-2  mduced  the 
expression  of the  1.5-  and  3.5-kb  mR.NA  species  that are 
typical  for  the  alpha  chain  (29,  32)  suggesting  that  IL-2 
elicits its effects through the high-affinity IL-2 receptor, 
Modulation of Chemokine  Responsiveness by IL-2.  The  es- 
sential role of IL-2 is illustrated in Fig.  3.  Lymphocytes that 
were fully responsive to MCP-1  and RANTES  after a  10-day 
Figure  2.  Chemotaxis  correlates 
with  chemokine  receptor  expres- 
sion.  CD45ILO + lymphocytes were 
cultured in the presence  of 400 U~ 
ml [L-2 for up to 12 d, and tested for 
in  vitro  migrauon  and  chernokine 
receptor  expression.  Chemotaxis to 
l nM MCP-1, 10 nM tLANTES, 10 
nM  IL-8,  and  random  migration 
(control)  in dependence of 1L-2 ex- 
posure time is shown  (mean  num- 
ber +  SD of migrating cells per five 
high power fields in triplicate  wells). 
Total  IZNA from  IL-2 conditioned 
CD45RO ~ lymphocytes  and freshly 
isolated  monocytes (M) and neutro- 
phils  (N)  was analyzed  by Northern 
blotting (10  ~g per lane).  The  blot 
was  sequentially  hybridized  with 
-~2p-labeled cDNA  probes  fbr  the 
MCP-I  (CC-CKP,2),  IkANTES 
(CC-CKRI),  IL-8  (ILS-R1/R2), 
and IL-2 (o~ chain) receptors.  Counts 
ot the ~2P-labeled chemokiue recep- 
tor  R.NA  and  the  ethidium  bro- 
mide-stained 28S  P,  NA  were  mte- 
gwated using the hnageQuant software 
and expressed  as relative  R.NA  lev- 
els. The position of the 18S and 28S 
ribosomal  R.NA  is  indicated.  The 
data  are representative of four inde- 
pendent experintents. 
exposure  to  IL-2  rapidly  lost  the  ability  to  mi~ate  when 
IL-2 was removed.  Chemotaxis toward MCP-l  or RANTES 
decreased to "~30% within 8  h, and fell below  10% in 48 h. 
When  1L-2 was supplied again chemotactic responses were 
largely  restored  within  the  following  48  h.  This  modula- 
tory. effect of IL-2  was  concentration dependent,  as shown 
in  Fig.  4  A,  and  was  observed  in  I0  separate  experiments 
performed  with  cells from different donors  (Table  2).  The 
loss and recovery of chemotactic responsiveness was  paral- 
Figure  3.  Continuous  pres- 
ence  of  IL-2  is  required  for 
chemokine responsiveness. CD45- 
RO* lymphocytes were cultured 
fhr  10 d  m  the presence of 400 
U/ml  IL-2,  washed  three  tunes 
with  PBS  and  further  cultured 
with or without IL-2 (open and 
closed symbols, respectively).  Af- 
ter  2  d,  400  U/m]  IL-2  was 
added  to  the  IL-2-free  cultures 
(arrow).  Chemotactic  responses 
to  I  tiM  MCP-1  or  10  nM 
RANTES are shown as in Fig. 2. 
Total  RNA  was  analyzed  by 
Northern  blotting  (10  Ixg  per 
lane).  The blot was sequentially 
hybridized with 32p-labeled  cDNA 
probes fbr CC-CKR1  and CC- 
CKR2  and  hybridization  was 
quantitated as described in Fig. 2. 
The  data  are  representative  of 
three independent experiments. 
572  lL-2-induced Chemokine Responsiveness ofT Cells Table 2.  Loss  and Recovery of Chemotactic Responsiveness ls 
Regulated by IL-2 
Time (h)*  MCP-I*  R_ANTES* 
-IL-2  8  40.5  •  15.0  47.7  +  17.6 
24  10.8  •  8.0  18.2  •  13.2 
48  5.6  •  3.9  12.3  •  8.1 
+IL-2  24  62.4  •  11.8  72.3  •  21.4 
48  89.7  •  28.0  88.0  +-- 27.2 
*CD45RO + lymphocytes were cultured for 10 to  13 d in the presence 
of 400 U/ml IL-2, washed three times with PBS, and further cultured 
for up to 48 h  without IL-2. After this time, the medium was supple- 
mented with 400 U/ml IL-2 and incubation was continued for 24 or 48 h. 
$Chemotactic responses to 1 nM MCP-1 and 10 nM RANTES are ex- 
pressed as percent migration with respect to the controls (cells cultured 
in the presence of IL-2). Mean values +  SD of 10 independent experi- 
ments. 
leled  by  changes  in  receptor  expression.  CC-CKR1  and 
CC-CKR2 transcripts fell rapidly upon withdrawal of IL-2 
and  almost regained the  initial values after renewed  addi- 
tion of IL-2 (Fig.  3). Although the response was similar for 
both receptors, the changes in CC-CKR1 mRNA were al- 
ways more pronounced. 
The effect of IL-2 was compared with that of several cy- 
tokines known to act on T  lymphocytes. CD45RO §  cells 
conditioned with IL-2 were kept for 2  d in IL-2-deficient 
medium and were then  exposed to  IL-2 or another cyto- 
kine. As shown in Fig. 4 B, the chemotactic responsiveness 
to MCP-1 and RANTES, which was lost upon withdrawal 
of IL-2, was partially restored by IL-4,  IL-10,  and  IL-12, 
but remained virtually unaffected by treatment with IL-13, 
IFN'r,  IL-l[3,  and  TNF-or  IL-12 was  the  most  effective 
substitute which led to the recovery of 15  and 40% of the 
chemotactic activity of MCP-1  and RANTES, respectively 
(Fig.  4 B). 
Lymphocyte  Activation  with  Anti-CD3  and  Anti-CD28. 
The state of activation of lymphocytes is considered to af- 
fect  their  responsiveness  to  chemokines,  and  it  was  re- 
ported that anti-CD3 antibodies enhanced the migration of 
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Figure 4.  Recovery of chemokine responsiveness. Dependence on IL-2 
concentration and effects of different cytokines. CD45RO + lymphocytes 
were cultured for 12 d  in the presence of 400 U/ml IL-2, washed three 
times with PBS, further cultured for 2 d without IL-2, and then the me- 
dium was supplemented with increasing concentrations oflL-2 (A) or dif- 
ferent cytokines (/3). These were 400 U/ml IL-2,  100 U/ml IFN%  and 
100 ng/ml oflL-4, IL-10, IL-12, IL-13, IL-113, or TNFo~.  After two days 
the chemotactic responses to  1  nM MCP-1  or  10 nM  RANTES  were 
tested.  Mean  numbers of migrating cells per  five  high-power fields in 
triplicate wells were  deterrmned. Values in  (A) were normalized by set- 
ting to 100% the response obtained with cells exposed to 400 U/ml IL-2. 
Mean values ~  SD from three independent experiments. 
T  cells  toward  MIP-lo~,  MIP-I~,  and  IP10  (9,  33).  As 
shown  in  Fig.  5,  neither  chemotaxis  toward  MCP-1  or 
RANTES  nor  the  expression  of  the  corresponding 
chemokine receptors  could be induced  in  freshly isolated 
CD45RO + lymphocytes by exposure to anti-CD3.  These 
results suggest that signaling through  TCR/CD3  complex 
is not sufficient for induction  of responsiveness to chemo- 
Figure  5.  Effect  of  anti-CD3. 
Freshly  isolated  CD45RO +  lym- 
phocytes were  used as  such  (0  h) 
or after culturing for 8  h  on plates 
with or without coating with anti- 
CD3  in  the  absence  of  IL-2. 
Migration  in  response  to  1  nM 
MCP-1, 10 nM R.ANTES, or me- 
dium alone (control),  and chemo- 
kine receptor expression were then 
tested  as  described  in  Fig.  2. 
CD45RO + lymphocytes that were 
cultured for 13 d in the presence of 
400  U/ml  IL-2  were  used  for 
comparison.  The  data  are  repre- 
sentative of three independent ex- 
periments. Figure  6.  Effect  of  combined 
treatment  with  anti-CD3  and  anti- 
CD28.  Freshly isolated  CI)45R.O + 
lymphocytes  were  cultured  for 3  d 
on plates coated with anti-CD3 in a 
medium  containing  soluble  anti- 
CD28  but  no  IL-2.  Medium  con- 
taining  50  U/ml  IL-2  was  then 
added  (arrow) and  the  culture  was 
continued  for  up  to  11  d.  Migra- 
tion in response  to 1 nM MCP-1 or 
10  nM  RANTES,  and  chemokine 
receptor  expression  were  tested  at 
different times as described in Fig. 2. 
One out of two independent  experi- 
ments is shown. 
kines,  and  that  co-stimulation  such  as  activation  of  the 
CD28  antigen  (34,  35) may be required. 
To  test this  hypothesis  we  examined  the  co-stimulatory 
effect  of  anti-CD28  in  combination  with  anti-CD3. 
Freshly isolated CD45RO  §  lymphocytes were activated for 
3  d  with immobilized anti-CD3 and soluble anti-CD28  an- 
tibodies and then diluted into medium containing IL-2. Al- 
though  they underwent  blast formation and massive prolif- 
eration,  the cells did not become responsive to chemokines 
unless  IL-2  was  added  (Fig.  6).  Similar  effects  were  ob- 
tained with another mitogen, phytohemagglutinin  (Fig.  1 A 
and  data  not  shown).  These  observations  suggested  that 
anti-CD3 and anti-CD28  are not involved in the induction 
of chemokine  receptor  expression,  but  actually  appear  to 
counteract  the  effect of IL-2.  As shown  in  Fig.  7,  this  ap- 
pears  to  be  the  case:  CD45RO  +  lymphocytes  made  re- 
sponsive to MCP-1  and RANTES  by treatment with IL-2 
rapidly lost receptor expression  and  the capacity to migrate 
after  exposure  to  anti-CD3  and  anti-CD28  although  IL-2 
was still present.  Chemotaxis toward MCP-1  and RANTES 
fell to  10-20%  within  3  h,  and  was  undetectable  after  24 
and 72 h.  Concomitantly,  a rapid and persistent decrease of 
chemokine receptor expression was observed. 
Discussion 
In recent years numerous laboratories have examined the 
responses  of lymphocytes  to  chemokines,  but  the  results 
have  often  been  contradictory.  Work  with  lymphocyte 
subpopulations  and analysis of the phenotype of the migrat- 
ing cells showed that CC  rather than CXC-chemokines  act 
on  lymphocytes  and  that  CD45RO  +,  memory  phenotype 
cells are the  main  responders  (8,  12).  Using blood-derived 
CD45RO  + lymphocytes,  we have studied  the mechanisms 
Figure  7.  Down-regulation 
of chemokine responsiveness by 
anti-Cl)3 and anti-CD28.  C1)45- 
1~O  +  lymphocytes  cultured  for 
12 d with 400  U/nil IL-2  were 
cultured  further  under the same 
conditions  (open symbols)  or  on 
plates  coated  with  anti-C1)3  in 
the presence of IL-2 (400 U/ml) 
and  soluble  anti-CD28  (dosed 
s),mbols).  Mig-cation in  response 
to  1  nM  MCP-1  or  10  nM 
P,  ANTES,  and  chemokine  re- 
ceptor expression were tested  at 
different  times  as  described  in 
Fig. 2.  The data are representa- 
tive of three independent  experi- 
nlents. 
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show that IL-2 induces the expression of two CC chemo- 
kine receptors, CC-CKR1  and CC-CKR2, which are se- 
lective for RANTES  and MCP-1,  respectively, and inde- 
pendently signal for migration. 
In contrast to IL-2, other stimuli that also induce the ac- 
tivation and proliferation of CD45RO + cells, like antibod- 
ies against the TCR/CD3  complex and the CD28 antigen 
or phytohemagglutinin,  did not elicit chemotactic activity 
and  CC  chemokine  receptor expression,  but  actually de- 
layed the effect of IL-2. This observation may be taken to 
suggest that  T  cells  become responsive to  recruitment by 
chemokines produced at inflanmlatory sites after IL-2 me- 
diated expansion and not already during antigen-dependent 
activation in the draining lymph nodes.  In agreement with 
the  present results,  Gao et al.  (18)  reported that lympho- 
cytes exposed to phytohemagglutinin do not express CC- 
CKR1  mRNA,  and  work  from  our  own  laboratory 
showed a marked reduction of migration of cloned human 
T  cells after treatment with anti-CD3 (11).  An opposite ef- 
fect,  however,  was  reported  by Taub  et al.  (9)  on blood 
lymphocytes. 
While progressively enhancing migration toward MCP-1, 
RANTES and the other CC chemokines, exposure to IL-2 
did not induce the expression of IL-8 receptors and did not 
elicit  chemotactic  responsiveness  of CD45RO +  lympho- 
cytes to IL-8. The present results are in agreement with our 
previous  observations with  cloned  T  cells  (11)  and  NK- 
cells  (36),  which  only  responded  to  CC  chemokines.  A 
lack of chemotactic activity of IL-8 as well as IP10 for T 
lymphocytes was  also  reported  by Roth  et  al.  (13)  who 
studied  transendothelial  migration.  Although  the  contro- 
versy about lymphocyte responsiveness to IL-8 may remain 
(1),  the demonstration of high-level CC-CKR1  and CC- 
CKR2  expression  in  the  absence of detectable  transcripts 
for the IL-8 receptors adds substantial new evidence against 
a role of IL-8 in lymphocyte recruitment. 
The close correlation between the numbers of migrating 
cells in response to MCP-1, MCP-2,  MCP-3,  RANTES, 
MIP-lix,  and  MIP-I[3, and  the  levels of CC-CKR1  and 
CC-CKR2  expression suggests that these  receptors are of 
major importance for lymphocyte recruitment. CC-CKR1 
was  originally described  as  a RANTES/MIP-lot  receptor 
(17,  18), and CC-CKR2, which occurs in two alternatively 
spliced forms, was shown to bind MCP-1  and MCP-3 but 
not RANTES or MIP-1~x (19,  37, 38). Two additional CC 
chemokine receptors were reported recently, CC-CKR3, 
which binds eotaxin (20),  and CC-CKR4 which has high 
affinity for RANTES  and  MIP-lot  (22).  CC-CKR4  was 
cloned from a human basophilic  cell line  and reported  to 
occur  at  low  (RT-PCR  detectable)  levels  in  resting  and 
IL-2--stimulated blood T  lymphocytes (21).  Since RANTES 
and MCP-1  are major attractants  for T  cells (11,  13) and are 
selective for CC-CKR1 and CC-CKR2, respectively, these 
receptors were best suited for assessing  expression as a cor- 
relate of migration. 
IL-2 has pleiotropic regulatory effects on leukocytes and 
was shown  to  enhance  various T  cell responses including 
antigen-specific  proliferation  and  cytotoxicity  (39).  The 
beta and gamma chains  of the  IL-2 receptor are constitu- 
tively  expressed  in  resting  blood  lymphocytes  (40,  41), 
whereas the alpha chain, which is required for formation of 
the high-affinity receptor, is expressed only after T  cell ac- 
tivation  (42,  43).  In agreement with previous reports  (30, 
31),  IL-2  treatment  of CD45RO +  lymphocytes induced 
the expression of the alpha chain. The time dependence of 
this  effect  was  closely  correlated  with  the  expression  of 
CC-CKR1 and CC-CKR2, suggesting that chemokine re- 
ceptors are induced by signaling through  the high  affinity 
IL-2 receptor. It will be interesting to study the role of sig- 
nal  transducers  and  activators  of transcription  (44)  in  the 
regulation of chemokine receptor expression. 
It is well known that chemokine receptors are subjected 
to agonist-dependent desensitization  and that chemokine- 
challenged  leukocytes  rapidly  become  refractory  to  re- 
peated stimulation  (1).  As shown for C5a,  desensitization 
is  related to  the  phosphorylation of serine  residues in  the 
carboxy-terminal region of the receptor (45-47). Desensiti- 
zation could regulate the progress of a response like chemo- 
taxis which is guided by increasing chemokine concentrations 
along a gradient.  Receptor sequestration or internalization 
is another possible way to influence  responsiveness.  It has 
been shown  that ligand-bound  IL-8 receptors on neutro- 
phils are rapidly endocytosed and recycled (48,  49), but no 
corresponding information is available on CC  chemokine 
receptors.  Receptor numbers  can also  be regulated  at the 
level  of gene  expression.  Changes  in  IL-8R  expression 
were observed in neutrophils  after treatment with G-CSF 
and  LPS  (50),  and a  decrease  in  the  number of MCP-1- 
binding  sites  and  responsiveness  to  MCP-1  was  reported 
during  differentiation  of THP-1  cells  by  phorbol  esters 
(51).  By  comparison,  the  effects  of IL-2  on  CD45RO + 
lymphocytes are  much  more  pronounced.  The  strict  de- 
pendence  of receptor  expression  and  chemokine  respon- 
siveness on IL-2 suggests that lymphocytes may be selected 
for  immigration  into  sites  of inflammation  and  immune 
intervention  through  activation  and  expansion  by  IL-2, 
which  must  be  regarded  as  a  major  regulatory  factor  of 
lymphocyte migration in vivo. The IL-2-like effects of IL-4, 
IL-10, and IL-12 could be explained by the sharing of re- 
ceptor  subunits  or  similarities  in  the  signal  transduction 
pathways. 
In  this  paper  we  have  shown  that  IL-2  enhances  CC 
chemokine  receptor  expression  and  chemotactic  respon- 
siveness  of  T  lymphocytes.  The  upregulation  of  CC- 
CKR1  is  a  prerequisite  for  the  activities  of RANTES, 
MIP-lcx, and MIP-I[3, the three chemokines that were re- 
cently  reported  to  suppress  HIV  replication  in  CD4 +  T 
cells  (52).  If this effect is mediated by receptors and signal 
transduction mechanisms known to elicit migration, it can 
be assumed that treatment with IL-2 may enhance the anti- 
viral activity of T  lymphocytes. 
575  Loetscher et al. We thank Dr.  I.  Clark-Lewis (Hanson  Centre for Cancer Research, Adelaide, South Australia)  for the 
chemical synthesis of the chemokines used in this study, Dr. A. Lanzavecchia  (Basel Institute for Immunol- 
ogy), for monodonal antibodies and human recombinant IL-2, and Dr. J. Ledbetter (Bristol-Myers Squibb, 
Seattle, WA) for anti-CD28. Donor blood buffy coats were provided by the Swiss Central Laboratory Blood 
Transfusion  Service, SILK. We are grateful to Dr. B. Dewald for critically reading the manuscript. 
This work was supported by Grant 31-039744.93 of the Swiss National Science Foundation to M. Baggio- 
lini and B. Moser, and grants of the Swiss and the Bemese Cancer Ligues to M. Baggiolini. Dr. B. Moser is 
recipient of a career development award of the Max Clo&ta Foundation. 
Address correspondence to Plus Loetscher, Theodor Kocher Institute, University of Bern, P.O. Box CH- 
3000 Bern 9, Switzerland. 
Received  for publication  8 April 1996 and in revised  form  14June  1996. 
References 
1.  Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 
and related chemotactic cytokines--CXC and  CC  chemo- 
kines. Adv. Immunol. 55:97-179. 
2.  Schall,  T.J.,  and K.B. Bacon.  1994.  Chemokines, leukocyte 
trafficking, and inflammation. Curt. Opin. Immunol. 6:865-873. 
3.  Yoshinmra, T., E.A. Robinson, S. Tanaka, E. Appella,  J. Ku- 
ratsu,  and E.J.  Leonard.  1989.  Purification and amino acid 
analysis  of two  human  glioma-derived monocyte chemoat- 
tractants.J. Exp. Med.  169:1449-1459. 
4.  Van Damme, J., P. Proost, J.-P. Lenaerts, and G. Opdenak- 
ker. 1992.  Structural and functional identification of two hu- 
man, tumor-derived monocyte chemotactic proteins (MCP-2 
and  MCP-3)  belonging to  the  chemokine  family. J.  Exp. 
Med. 176:59-65. 
5.  Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and 
M.  Baggiolini. 1995.  Actions of the  chemotactic cytokines 
MCP-1, MCP-2, MCP-3, KANTES, MIP-IoL and MIP-I~3 
on human monocytes. Eur.J. Immunol. 25:64--68. 
6.  Dahinden,  C.A., T.  Geiser, T.  Brunner,  V.  von Tscharner, 
D.  Caput,  P.  Ferrara, A. Minty,  and M.  Baggiolini.  1994. 
Monocyte chemotactic protein 3 is a most effective basophil- 
and  eosinophil-activating chemokine. J.  Exp.  Med.  179: 
751-756. 
7.  Baggiolini, M., and C.A. Dahinden.  1994.  CC  chemokines 
in allergic inflammation. Immunol. Today. 15:127-133. 
8.  Schall,  T.J.,  K. Bacon,  K.J.  Toy, and D.V.  Goeddel.  1990. 
Selective attraction of monocytes and T  lymphocytes of the 
memory phenotype by cytokine RANTES.  Nature  (Lond.). 
347:669-671. 
9.  Taub,  D.D.,  K.  Conlon,  A.R. Lloyd, J.J.  Oppenheim,  and 
D 0. Kelvin. 1993.  Preferential migration of activated CD4 + 
and CD8 + T  cells in response to MIP-10t and MIP-I[3. Sci- 
ence (Wash. DC). 260:355-358. 
10. Schall,  T.J.,  K.  Bacon,  R.D.R.  Camp, J.W.  Kaspari,  and 
D.V. Goeddel. 1993. Human macrophage inflammatory pro- 
tein  ~  (MIP-1o  0  and  MIP-I~  chemokines  attract  distinct 
populations oflymphocytes..]. Exp. Med.  177:1821-1825. 
11. Loetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. 
Moser.  1994.  The monocyte chemotactic proteins, MCP-I, 
MCP-2 and MCP-3, are major attractants for human CD4 ~ 
and CD8 + T lymphocytes. FASEBJ. 8:1055-1060. 
12. Carr,  M.W.,  S.J. Roth,  E.  Luther,  S.S.  Rose,  and  T.A. 
Springer. 1994. Monocyte chemoattractant protein 1 acts as a 
T-lymphocyte chemoattractant.  Proc. Natl.  Acad. Sci. USA. 
91:3652-3656. 
13. Roth,  S.J.,  M.W.  Cart,  and  T.A.  Springer.  1995.  C-C 
chemokines, but not the  C-X-C  chemokines intedeukin-8 
and  interferon-gamma  inducible  protein-10,  stimulate 
transendothelial chemotaxis of T  lymphocytes. Eur. J. lmmu- 
nol. 25:3482-3488. 
14. Murphy,  P.M.  1994.  The  molecular biology of leukocyte 
chemoattractant receptors. Annu. Rev. Immunol. 12:593-633. 
15. Holmes,  W.E., J.  Lee, W.-J.  Kuang,  G.C.  Rice, and  W.I. 
Wood. 1991.  Structure and functional expression of a human 
interleukin-8 receptor. Science (Wash. DC). 253:1278-1280. 
16. Murphy, P.M., and H.L. Tiffany. 1991.  Cloning of comple- 
mentary  DNA  encoding a  functional human  interleukin-8 
receptor. &ience (Wash. DC). 253:1280-1283. 
17. Neote,  K.,  D.  DiGregorio, J.Y.  Mak,  ti,.  Horuk,  and T 0. 
Schall.  1993.  Molecular cloning, functional expression, and 
signaling characteristics of a C-C chemokine receptor.  Cell. 
72:415--425. 
18. Gao, J.-L., D.B. Kuhns, H.L. Tiffany, D. McDermott, X. Li, 
U.  Francke, and  P.M_ Murphy.  1993.  Structure  and func- 
tional  expression  of the  human  macrophage  inflammatory 
protein 10e/KANTES receptor./. Exp. Med. 177:1421-1427. 
19. Charo,  1.F.,  S.J. Myers,  A.  Herman,  C.  Franci,  AJ.  Con- 
nolly, and S.R. Coughlin. 1994. Molecular cloning and func- 
tional expression of two monocyte chemoattractant protein 1 
receptors reveals alternative splicing of the carboxyl-tenninal 
tails. Proc. Natl. Acad. &i.  USA. 91:2752-2756. 
20. Combadiere, C., S.K_ Ahuja, and P.M. Murphy. 1995. Clon- 
ing  and  functional  expression  of a  human  eosinophil  CC 
chemokine receptor. J.  Biol. Chem. 270:16491-16494;  Cor- 
rection..]. Biol. Chem. 270:30235. 
21. Power,  C.A.,  A.  Meyer,  K.  Nemeth,  K.B.  Bacon,  AJ. 
Hoogeweff, A.E.I. Proudfoot, and T.N.C. Wells. 1995. Mo- 
lecular  cloning  and  functional  expression  of a  novel  CC 
chemokine  receptor  cDNA  from  a  human  basophilic cell 
line. d. Biol. Chem. 270:19495-19500. 
22.  Hoogewerf, AJ., D. Black, A.E.]. Proudfoot, T.N.C. Wells, 
and  C.A.  Power.  1996.  Molecular cloning of murine  CC 
CKR-4 and high affinity binding of chemokines to murine 
and  human  CC  CKR-4.  Biochem. Biophys.  Res.  Commun. 
218:337-343. 
23. Moser, B., L. Barella,  S. Mattei, C. Schumacher, F. Boulay, 
M.P. Colombo, and M. Baggiolini. 1993. Expression of tran- 
scripts for two interleukin 8 receptors in human phagocytes, 
576  IL-2-induced Chemokine Responsiveness ofT Cells lymphocytes and melanoma cells. Biochem.  J. 294:285-292. 
24. Clark-Lewis,  I.,  B.  Moser,  A.  Walz,  M.  Baggiolini,  G.J. 
Scott, and R.. Aebersold. 1991.  Chemical synthesis, purifica- 
tion, and characterization of two inflammatory proteins, neu- 
trophil activating peptide 1 (interleukin-8) and neutrophil ac- 
tivating peptide 2. Biochemistry. 30:3128-3135. 
25. Colotta, F., G. Peri, A. Villa, and A. Mantovani. 1984.  Rapid 
killing ofactinomycin D-treated tumor cells by human mono- 
nuclear  cells.  I.  Effectors belong  to  the  monocyte-macro- 
phage lineage.J. Immunol. 132:936-944. 
26. Miltenyi, S.,  W.  Mueller, W.  Weichel,  and A.  R.adbmch. 
1990.  High gradient magnetic cell separation with  MACS. 
Cytometry.  1  l:231-238. 
27.  Chomczynski, P_, and N.  Sacchi.  1987.  Single-step method 
of R.NA isolation by acid-guanidinium thiocyanate-phenol- 
chloroform extraction. Anal.  Biochem. 162:156-159. 
28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989.  Molecular 
Cloning: A Laboratory Manual. Cold Spring Harbor Labora- 
tory Press, Cold Spring Harbor, N.Y. 545 pp. 
29. Nikaido, T., A. Shimizu, N. Ishida, H. Sabe, K. Teshigawara, 
M.  Maeda,  T.  Uchiyama, J.  Yodoi,  and  T.  Honjo.  1984. 
Molecular cloning of cDNA encoding human interleukin-2 
receptor. Nature (Lond.). 31l:631-635. 
30. Hard-Bellman, A., J. Bertoglio, A. Quillet, C. Marchiol, H. 
Wakasugi, Z.  Mishall, and D.  Fradelizi. 1986.  Interleukin 2 
(IL 2)  up-regulates its own  receptor on  a subset of human 
unprimed  peripheral blood  lymphocytes and  triggers  their 
proliferation.J. Immunol. 136:2463-2469. 
3l. Siegel, J.P., M. Sharon, P.L. Smith, and W.J. Leonard. 1987. 
The  IL-2 receptor 13 chain  (I070): Role in mediating signals 
for LAK, NK, and proliferative activities. Science (Wash. DC). 
238:75-78. 
32.  Leonard, W.J., J.M.  Depper, G.R.  Crabtree, S. R.udikoff, J. 
Pumphrey, R..J. P~obb, M. Kr6nke, P.B. Svetlik, N.J. Peffer, 
T.A. Waldmann, and W.C. Greene. 1984. Molecular cloning 
and expression ofcDNAs for the human interleukin-2 recep- 
tor. Nature (Lond.). 311:626-631. 
33. Taub, D.D.,  A.R..  Lloyd, K. Conlon, J.M.  Wang, J.R.  Or- 
taldo, A. Harada, K. Matsushima, D.J.  Kelvin, and J.J.  Op- 
penheim.  1993.  Recombinant  human  interferon-inducible 
protein 10 is a chemoattractant for human monocytes and T 
lymphocytes and  promotes  T  cell adhesion  to  endothelial 
cells.J. Exp. Med.  177:1809-1814. 
34. June,  C.H., J.A. Bluestone, L.M. Nadier, and C.B. Thomp- 
son. 1994. The B7 and CD28 receptor families. Immunol. To- 
day 15:321-331. 
35. Linsley, P.S., andJ.A. Ledbetter. 1993. The role of the CD28 
receptor during T  cell  responses to antigen. Annu.  Rev.  Im- 
munol. 11:191-212. 
36. Loetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. 
Moser.  1996.  Activation of NK cells by CC chemokines-- 
Chemotaxis, Ca  2+  mobilization, and enzyme release. J.  Im- 
munol. 156:322-327. 
37.  Franci, C., L.M. Wong, J.  Van Damme,  P. Proost, and I.F. 
Charo.  1995.  Monocyte cbemoattractant protein-3, but not 
monocyte chemoattractant protein-2, is a functional ligand of 
the human monocyte chemoattractant protein-1 receptor. J. 
lmmunot, t54:65l 1-6517. 
38. Myers, S.J., L.M. Wong, and I.F. Charo.  1995.  Signal trans- 
duction  and  ligand  specificity  of  the  human  monocyte 
chemoattractant protein-1 receptor in transfected embryonic 
kidney cells._]. Biol. Chem. 270:5786-5792. 
39. Waldmann,  T.A.  t993.  The  IL-2/IL-2 receptor system: A 
target for rational immune intervention. Immunol. Today 14: 
264--269. 
40. Hatakeyama, M., M. Tsudo, S. Minamoto, T. Kono, T. Doi, 
T.  Miyata, M.  Miyasaka, and T. Taniguchi.  1989.  Interleu- 
kin-2 receptor [3 chain gene:  Generation of three forms by 
cloned human a  and [3 chain cDNA's. Science (Wash.  DC). 
244:551-556. 
41.  Takeshita, T., H. Asao, K. Ohtani, N.  Ishii, S. Kumaki, N. 
Tanaka,  H.  Munakata,  M.  Nakamura,  and  K.  Sugamura. 
1992.  Cloning of the gamma chain of the human IL-2 recep- 
tor. Science (Wash. DC). 257:379-382. 
42. Smith, K.A. 1988.  Interleukin-2: Inception, impact, and im- 
plications. Science (Wash. DC). 240:1169-1176. 
43. Waldmann,  T.A.  1991.  The  interleukin-2 receptor. J.  Biol. 
Chem. 266:2681-2684. 
44.  lhle, J.N.  1995.  Cytokine receptor signalling. Nature (Lond.). 
377:591-594. 
45. Tardif, M., L. Mery, L. Brouchon, and F. Boulay. 1993.  Ag- 
onist-dependent phosphorylation of N-formylpeptide and ac- 
tivation  peptide  from  the  fifth  component  of  C  (C5a) 
chemoattractant receptors in differentiated HL60 cells. J.  Im- 
munol. 150:3534-3545. 
46. Ali, H.,  R..M.R.ichardson,  E.D.  Tomhave, J.R..  Didsbury, 
and R.. Snyderman.  1993.  Differences in phosphorylation of 
formylpeptide and  C5a  chemoattractant receptors  correlate 
with differences in desensitization.  J. Biol. Chem. 268:24247- 
24254. 
47.  Giannini, E., L. Brouchon, and F. Boulay.  1995.  Identifica- 
tion of the  major phosphorylation sites in human  C5a ana- 
phylatoxin receptor in vivo. J. Biol. Chem. 270:19166-19172. 
48.  Samanta, A.K., S.  Dutta,  and E.  Ali. 1993.  Modification of 
sulfhydryl  groups  of interleukin-8  (IL-8)  receptor  impairs 
binding of IL-8 and IL-8-mediated chemotactic response of 
human  polymorphonuclear neutrophils. J.  Biol. Chem.  268: 
6147-6153. 
49. Chuntharapai, A., and K.J. Kim. 1995. R.egulation of the ex- 
pression of IL-8 receptor A/B by IL-8: possible functions of 
each receptor.J. Immunol. 155:2587-2594. 
50. Lloyd, A.R.., A. Biragyn, J.A. Johnston, D.D. Taub, L.L. Xu, 
D.  Michiel, H.  Sprenger, J.J.  Oppenheim, and D.J.  Kelvin. 
1995.  Granulocyte-colony stimulating factor and lipopolysac- 
charide regulate the expression of intedeukin 8 receptors on 
polymorphonuclear leukocytes. J.  Biol. Chem.  270:28188- 
28192. 
51. Denholm, E.M., and G.P. Stankus. 1995. Changes in the ex- 
pression of MCP-1 receptors on monocytic THP-1 cells fol- 
lowing differentiation to macrophages with phorbol myristate 
acetate. Cytokine. 7:436-440. 
52.  Cocchi,  F.,  A.L.  DeVico,  A.  Garzino-Demo,  S.K.  Arya, 
R..C. Gallo, and P. Lusso.  1995.  Identification of RANTES, 
MIP-I~x, and M1P-113 as the major HIV-suppressive factors 
produced by CD8 + T  cells.  ,Science (Wash.  DC). 270:1811- 
i815. 
577  Loetscher et al. 